THE UNITED LABORATORIES INTERNATIONAL HOLDINGS LIMITED

Otros idiomas The United Laboratories International Holdings Limited

Acciones

3933

KYG8813K1085

Mercado cerrado - Hong Kong S.E. Otros sitios de cotización 10:08:20 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
9,48 ^HKD	-2,97 %		-1,15 %	+35,24 %

27/03	The United Laboratories International Holdings Limited informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023	CI
27/03	Aumentan los beneficios de The United Laboratories International en 2023 gracias a unos mayores ingresos	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

The United Laboratories International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
The United Laboratories International's 2023 Profit Rises on Higher Revenue	27/03
The United Laboratories International Holdings Limited Recommends Payment of Final Dividend for the Year Ended 31 December 2023	26/03
The United Laboratories International Holdings Limited Recommends Payment of Special Dividend for the Year Ended 31 December 2023	26/03
The United Laboratories International Forecasts Profit Surge in 2023	15/03
The United Laboratories International Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	14/03
United Laboratories Postpones EGM Due to Bad Weather	09/10/23
United Laboratories Subsidiary Gets US FDA Nod for Injectable for Diabetes; Shares Rise 8%	27/09/23
The United Laboratories International Holdings Limited Announces FDA Approval of IND for UBT251 Injection	26/09/23
The United Laboratories International Holdings Limited Announces Interim Dividend for Six Months Ended 30 June 2023, Payable on 11 October 2023	21/09/23
United Laboratories Controlling Shareholder to Sell 64 Million Shares	19/09/23
United Laboratories International Unit Gets Regulatory Nod to Conduct Trial on TUL01101 Tablets	11/09/23
Chinese Regulator Allows Clinical Trial of United Laboratories' Fatty-Liver Drug	08/09/23
The United Laboratories International Holdings Limited Announces Application for the Clinical Trial of Class 1 Innovative New Drug UBT251 Injection	08/09/23
United Laboratories International Says Two Products Pass Consistency Evaluation	07/09/23
China Greenlights United Laboratories' Clinical Trial for Obesity Injection; Shares Rise 4%	04/09/23
The United Laboratories International Holdings Limited Announces Approval for Clinical Trial of Ubt251 Injection on Indication of Overweight or Obesity	03/09/23
The United Laboratories International Holdings Limited Announces Ordinary Interim (Semi-Annual) Dividend for Six Months Ended 30 June 2023	30/08/23
United Laboratories' H1 Profit Doubles; Shares Fall 4%	30/08/23
The United Laboratories International Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas The United Laboratories International Holdings Limited

Acciones

3933

KYG8813K1085

Otros idiomas

Filtros